Vesugen: Vascular Peptide Bioregulator

Vesugen is a tripeptide bioregulator (Lys-Glu-Asp) derived from vascular tissue, developed by the St. Petersburg Institute of Bioregulation and Gerontology as part of their comprehensive tissue-specific peptide bioregulator program. Where Cortagen targets the myocardium, Vesugen targets the vasculature itself — specifically the endothelium and vascular smooth muscle. Given that vascular aging underlies heart disease, stroke, kidney disease, erectile dysfunction, and most forms of organ failure, Vesugen holds broad relevance for cardiovascular health and longevity.

Vascular Aging and Endothelial Dysfunction

The endothelium is the single-cell layer lining the interior of all blood vessels. It regulates vascular tone through nitric oxide production, controls inflammation through cytokine expression, manages coagulation, and mediates the exchange of nutrients and waste products between blood and tissues. Endothelial dysfunction — characterized by reduced nitric oxide bioavailability, increased inflammatory activation, and impaired vascular repair — is the earliest and most fundamental change in cardiovascular disease development. Vesugen targets endothelial cell gene expression to restore more youthful patterns of function.

Mechanisms of Action

As a peptide bioregulator, Vesugen enters endothelial and smooth muscle cells and interacts with chromatin to regulate gene expression. It upregulates genes associated with nitric oxide synthase activity, endothelial cell survival, and vascular remodeling while suppressing pro-inflammatory gene expression. Animal studies have demonstrated that Vesugen reduces vascular stiffness, improves endothelium-dependent vasodilation, and reduces oxidative stress markers in vascular tissue. The tripeptide Lys-Glu-Asp has been identified as a specific signal for vascular tissue gene regulation based on its prevalence in naturally occurring vascular-derived peptides.

Cardiovascular and Systemic Applications

Vesugen is used clinically in Russia for hypertension management, atherosclerosis prevention, and general cardiovascular anti-aging. By restoring endothelial function, it may reduce blood pressure through enhanced nitric oxide-mediated vasodilation, reduce platelet aggregation through endothelial prostacyclin production, and slow the progression of atherosclerotic plaques. Its systemic vascular effects also make it relevant for microvascular conditions including erectile dysfunction (which is fundamentally a vascular condition), retinal vascular health, and kidney microvascular function.

Dosing and Protocol

Standard Vesugen protocols use 1-2 mg administered subcutaneously per day for 10-day cycles, repeated 2-4 times per year. Like all bioregulators, cyclical use rather than continuous administration is recommended. Vesugen is commonly combined with Cortagen for comprehensive cardiovascular support — the two compounds address different aspects of cardiovascular health (vascular endothelium vs. cardiac muscle) and are complementary in multi-system anti-aging protocols.

Integration with Lifestyle and Medical Management

Vesugen is not a replacement for lifestyle interventions that support cardiovascular health. Its benefits are best realized when integrated with evidence-based cardiovascular risk management including appropriate diet, exercise, blood pressure control, lipid management, and avoidance of smoking. The peptide bioregulator approach works at the gene regulation level, which can restore functional capacity, but it cannot override the ongoing endothelial damage caused by uncontrolled metabolic or lifestyle risk factors.

FAQ

How is Vesugen different from standard cardiovascular supplements? Supplements like CoQ10, omega-3s, and magnesium support cardiovascular health through nutritional and metabolic mechanisms. Vesugen operates differently — it directly regulates gene expression in vascular cells to restore patterns of function that decline with age. The two approaches are complementary and can be used together.

Is Vesugen appropriate for people with existing cardiovascular disease? Vesugen is used clinically in Russia for individuals with established cardiovascular disease as well as for prevention. Anyone with cardiovascular disease should not use Vesugen without physician oversight, particularly if on anticoagulants, as Vesugen's effects on platelet function could theoretically interact with these medications.

Does Vesugen improve sexual function? Erectile dysfunction has a strong vascular component, and improved endothelial function through enhanced nitric oxide bioavailability is a plausible mechanism for benefit. Some clinical reports from peptide bioregulator programs do note improvements in sexual function with Vesugen, though this is not a primary studied indication.

Track your supplements in Optimize.